LDLauren K. Dobson

Lauren K. Dobson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lauren K. Dobson has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Carl A. Gregory

    Department of Medical Physiology, Texas A&M College of Medicine, Bryan, USA

    3 shared publications
  • James Derr

    Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A & M University, College Station, TX

    2 shared publications
  • James N. Derr

    Affiliation Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas, United States of America

    2 shared publications
  • W. Brian Saunders

    Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas 77843, US

    2 shared publications
  • William Brian Saunders

    Department of Small Animal Clinical Sciences College of Veterinary Medicine and Biomedical Sciences, Texas A&M University College Station Texas USA

    2 shared publications
  • A. Zimin

    Department of Biomedical Engineering Center for Computational Biology Johns Hopkins University Baltimore MD 21205 USA

    1 shared publication

Latest Publications

  • Evaluation of a self-fitting, shape memory polymer scaffold in a rabbit calvarial defect model

    by Michaela R. Pfau, Felipe O. Beltran, Lindsay N. Woodard, Lauren K. Dobson, Shelby B. Gasson, Andrew B. Robbins, Zachary T. Lawson, W. Brian Saunders, Michael R. Moreno, Melissa A. Grunlan


  • De novo assembly and annotation of the North American bison (Bison bison) reference genome and subsequent variant identification

    by L. K. Dobson, A. Zimin, D. Bayles, E. Fritz‐Waters, D. Alt, S. Olsen, J. Blanchong, J. Reecy, T. P. L. Smith, J. N. Derr

    Summary: Genomic tools have improved the ability to manage bison populations and enhanced efforts to conserve this iconic species. These tools have been particularly useful for detecting introgression of cattle genome within bison herds but are limited by the need to use the cattle genome as a surrogate for mapping reads. This complicates efforts to distinguish the species of origin of chromosomal segments in individual bison at the genomic level. An assembly (Bison_UMD1.0) based on 75X genome coverage by Illumina and 454 reads was generated using the MaSuRCA assembler, generating a 2.81 Gigbases de novo reference genome from American bison. Comparison of bison and domestic cattle references identified 28 443 364 single nucleotide variants and 2 627 645 insertions/deletions distinguishing the species. Sequence alignment of an additional 12 modern bison samples and two historic bison samples to domestic cattle and bison references provides a dataset of genomic variants defining the different species and within‐species variation. This first annotated draft assembly represents a resource for the management and conservation of bison, as well as a means to study the effects on the genome of interspecies hybridization. The comparisons of historical bison sequences with the new bison reference identified genomic differences between modern and pre‐population bottleneck bison. The results support the application of genomics to enhance future research on disease, the establishment of satellite conservation herds and insight into bison and cattle speciation. The first genome assembly for bison and dataset provides a foundation that can be built upon as genetic technologies improve over the years.


  • Optimizing In Vitro Osteogenesis in Canine Autologous and Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells with Dexamethasone and BMP-2

    by Shelby B. Gasson, Lauren K. Dobson, Lyndah Chow, Steven W Dow, Carl A. Gregory, William Brian Saunders

    A growing body of work suggests that canine mesenchymal stromal cells (cMSCs) require additional agonists such as bone morphogenic protein-2 (BMP-2) for consistent in vitro osteogenic differentiation. BMP-2 is costly and may challenge the translational relevance of the canine model. Dexamethasone enhances osteogenic differentiation of human MSCs (hMSCs) and is widely utilized in osteogenic protocols. The aim of this study was to determine the effect of BMP-2 and dexamethasone on early- and late-stage osteogenesis of autologous and induced pluripotent stem cell (iPS)-derived cMSCs. Two preparations of marrow-derived cMSCs were selected to represent exceptionally or marginally osteogenic autologous cMSCs. iPS-derived cMSCs were generated from canine fibroblasts. All preparations were evaluated using alkaline phosphatase (ALP) activity, Alizarin Red staining of osteogenic monolayers, and quantitative polymerase chain reaction. Data were reported as mean ± standard deviation and compared using one- or two-way analysis of variance and Tukey or Sidak post hoc tests. Significance was established at P < 0.05. In early-stage assays, dexamethasone decreased ALP activity for all cMSCs in the presence of BMP-2. In late-stage assays, inclusion of dexamethasone and BMP-2 at Day 1 of culture produced robust monolayer mineralization for autologous cMSCs. Delivering 100 nM dexamethasone at Day 1 improved mineralization and reduced the BMP-2 concentrations required to achieve mineralization of the marginal cMSCs. For iPS-cMSCs, dexamethasone was inhibitory to both ALP activity and monolayer mineralization. There was increased expression of osteocalcin and osterix with BMP-2 in autologous cMSCs but a more modest expression occurred in iPS cMSCs. While autologous and iPS-derived cMSCs respond similarly in early-stage osteogenic assays, they exhibit unique responses to dexamethasone and BMP-2 in late-stage mineralization assays. This study demonstrates that dexamethasone and BMP-2 can be titrated in a time- and concentration-dependent manner to enhance osteogenesis of autologous cMSC preparations. These results will prove useful for investigators performing translational studies with cMSCs while providing insight into iPS-derived cMSC osteogenesis.


  • Open Access

    Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilities

    by Eoin P. McNeill, Suzanne Zeitouni, Simin Pan, Andrew Haskell, Michael Cesarek, Daniel Tahan, Bret H. Clough, Ulf Krause, Lauren K. Dobson, Mayra Garcia, et al.

    Approximately 10% of fractures will not heal without intervention. Current treatments can be marginally effective, costly, and some have adverse effects. A safe and manufacturable mimic of anabolic bone is the primary goal of bone engineering, but achieving this is challenging. Mesenchymal stem cells (MSCs), are excellent candidates for engineering bone, but lack reproducibility due to donor source and culture methodology. The need for a bioactive attachment substrate also hinders progress. Herein, we describe a highly osteogenic MSC line generated from induced pluripotent stem cells that generates high yields of an osteogenic cell-matrix (ihOCM) in vitro. In mice, the intrinsic osteogenic activity of ihOCM surpasses bone morphogenic protein 2 (BMP2) driving healing of calvarial defects in 4 weeks by a mechanism mediated in part by collagen VI and XII. We propose that ihOCM may represent an effective replacement for autograft and BMP products used commonly in bone tissue engineering.


  • Optimizing a Critical Gap Femoral Defect Model for Objective Assessment of Bone Regeneration in Dogs

    by E. Niemann, L.M. Dejardin, L.K. Dobson, B.M. Eichelberger, S.C. Kerwin, C.A. Gregory, W.B. Saunders

    Introduction: The objective of this study was to develop a canine nonunion femoral defect model using an angle-stable interlocking nail (AS-ILN) and methods to objectively characterize bone healing. Materials and Methods: Six healthy hounds (age: 2.5–6.5 year; weight: 23.7–35.5 kg) were treated with unilateral, 4 cm femoral ostectomies, followed by stabilization with an 8 mm AS-ILN. Dogs were randomly assigned to negative or positive control groups (n = 3/group). Positive control defects were treated with autologous cancellous bone graft. Healing was assessed at 0, 6, 12, and 18 weeks with radiography and CT/Mimics 16.0. At 18 weeks, dogs were humanely euthanized. Positive control femurs were biomechanically assessed for torsional stiffness, load to failure, and mode of failure. Histology was performed on both groups. Data were reported as median and range. Results: The AS-ILN provided appropriate stability without any implant-associated complications. Radiographic healing progressed in 0/3 negative and 3/3 positive control dogs from 0 to 18 weeks. Median bone volume increased from 535 mm3 to 662 mm3 (negative control) versus 1,375 mm3 to 3,999 mm3 (positive control). Median torsional failure load for positive control femurs was 12.0 Nm, versus 42.0 Nm for unoperated contralateral femurs. Histology confirmed nonunion or secondary bone healing. Discussion/Conclusion: When paired with the described outcome measures, use of an AS-ILN represents an advance in large animal bone regeneration models and accomplishes “refinement” and “reduction” goals of humane animal research. Acknowledgment: No proprietary interest. Funded by the Texas A&M Health Science Center and the Bone & Joint fund.

  • Genomic Structure and Tissue Expression of the NK-Lysin Gene Family in Bison

    by Mi Ok Lee, Lauren Dobson, Brian W Davis, Loren Skow, James Derr, James E Womack

    Antimicrobial peptides (AMPs) are a class of natural peptides with varying numbers of amino acids. They are principal components of innate immunity in vertebrates, encoding natural antibiotics and providing a protective response against a broad range of microbes including those responsible for tuberculosis, an important disease in bison. NK-lysins are AMPs that have been described in various organisms and are coded by a single gene in several mammalian species, including human. Recently, we described a family of 4 NK-lysin genes in cattle. Here, we examined NK-lysin genes in bison and identified 4 bison paralogs (NK1, NK2A, NK2B, and NK2C), although the current bison genome assembly annotates only 2 (NK1 and NK2). Sequence and phylogenetic analysis support the triplication of NK2 prior to the most recent common ancestor of bison and cattle. Comparative mapping of bison and cattle paralogs indicates that the NK-lysin family is located on bison chromosome 11 with well-conserved synteny of flanking genes relative to cattle. The 3 bison NK-lysin2 genes share high sequence similarity with each other. RNA-seq analysis demonstrates that NK2A, NK2B, and NK2C are expressed primarily in the lung, whereas NK1 is expressed at low levels in all tissues studied. This tissue expression pattern differs from that previously reported for cattle, suggesting some divergence in function since the evolutionary separation of the 2 species.


  • Open Access

    Mitochondrial Genome Analysis Reveals Historical Lineages in Yellowstone Bison

    by David Forgacs, Rick L. Wallen, Lauren K. Dobson, James N. Derr

    Yellowstone National Park is home to one of the only plains bison populations that have continuously existed on their present landscape since prehistoric times without evidence of domestic cattle introgression. Previous studies characterized the relatively high levels of nuclear genetic diversity in these bison, but little is known about their mitochondrial haplotype diversity. This study assessed mitochondrial genomes from 25 randomly selected Yellowstone bison and found 10 different mitochondrial haplotypes with a haplotype diversity of 0.78 (± 0.06). Spatial analysis of these mitochondrial DNA (mtDNA) haplotypes did not detect geographic population subdivision (FST = -0.06, p = 0.76). However, we identified two independent and historically important lineages in Yellowstone bison by combining data from 65 bison (defined by 120 polymorphic sites) from across North America representing a total of 30 different mitochondrial DNA haplotypes. Mitochondrial DNA haplotypes from one of the Yellowstone lineages represent descendants of the 22 indigenous bison remaining in central Yellowstone in 1902. The other mitochondrial DNA lineage represents descendants of the 18 females introduced from northern Montana in 1902 to supplement the indigenous bison population and develop a new breeding herd in the northern region of the park. Comparing modern and historical mitochondrial DNA diversity in Yellowstone bison helps uncover a historical context of park restoration efforts during the early 1900s, provides evidence against a hypothesized mitochondrial disease in bison, and reveals the signature of recent hybridization between American plains bison (Bison bison bison) and Canadian wood bison (B. b. athabascae). Our study demonstrates how mitochondrial DNA can be applied to delineate the history of wildlife species and inform future conservation actions.


  • Open Access

    Tissue residue levels of florfenicol, ceftiofur, tulathromycin, oxytetracycline, cydectin in white-tailed deer (Odocoileus virginanus) at 11, 21, and 31 days post intramuscular injection

    by Walt Cook, Dick Cain, Terry Hensley, Warren Bluntzer, William Lance, Lauren Dobson, Rebecca McDaniel, Mitch Lockwood, Bob Dittmar, Ryan Schoenberg, et al.


  • Open Access

    Genetic Analysis of the Henry Mountains Bison Herd

    by Dustin H. Ranglack, Lauren K. Dobson, Johan T. du Toit, James Derr

    Wild American plains bison (Bison bison) populations virtually disappeared in the late 1800s, with some remnant animals retained in what would become Yellowstone National Park and on private ranches. Some of these private bison were intentionally crossbred with cattle for commercial purposes. This forced hybridization resulted in both mitochondrial and nuclear introgression of cattle genes into some of the extant bison genome. As the private populations grew, excess animals, along with their history of cattle genetics, provided founders for newly established public bison populations. Of the US public bison herds, only those in Yellowstone and Wind Cave National Parks (YNP and WCNP) appear to be free of detectable levels of cattle introgression. However, a small free-ranging population (~350 animals) exists on public land, along with domestic cattle, in the Henry Mountains (HM) of southern Utah. This isolated bison herd originated from a founder group translocated from YNP in the 1940s. Using genetic samples from 129 individuals, we examined the genetic status of the HM population and found no evidence of mitochondrial or nuclear introgression of cattle genes. This new information confirms it is highly unlikely for free-living bison to crossbreed with cattle, and this disease-free HM bison herd is valuable for the long-term conservation of the species. This bison herd is a subpopulation of the YNP/WCNP/HM metapopulation, within which it can contribute significantly to national efforts to restore the American plains bison to more of its native range.


  • Open Access

    Genome-Wide Association Study Implicates Testis-Sperm Specific FKBP6 as a Susceptibility Locus for Impaired Acrosome Reaction in Stallions

    by Terje Raudsepp, Molly E. McCue, Pranab J. Das, Lauren Dobson, Monika Vishnoi, Krista L. Fritz, Robert Schaefer, Aaron K. Rendahl, James N. Derr, Charles C. Love, et al.

    Impaired acrosomal reaction (IAR) of sperm causes male subfertility in humans and animals. Despite compelling evidence about the genetic control over acrosome biogenesis and function, the genomics of IAR is as yet poorly understood, providing no molecular tools for diagnostics. Here we conducted Equine SNP50 Beadchip genotyping and GWAS using 7 IAR–affected and 37 control Thoroughbred stallions. A significant (PA and g.11040379C>A (p.166H>N) in exon 4 that were significantly associated with the IAR phenotype both in the GWAS cohort (n = 44) and in a large multi-breed cohort of 265 horses. All IAR stallions were homozygous for the A-alleles, while this genotype was found only in 2% of controls. The equine FKBP6 was exclusively expressed in testis and sperm and had 5 different transcripts, of which 4 were novel. The expression of this gene in AC/AG heterozygous controls was monoallelic, and we observed a tendency for FKBP6 up-regulation in IAR stallions compared to controls. Because exon 4 SNPs had no effect on the protein structure, it is likely that FKBP6 relates to the IAR phenotype via regulatory or modifying functions. In conclusion, FKBP6 was considered a susceptibility gene of incomplete penetrance for IAR in stallions and a candidate gene for male subfertility in mammals. FKBP6 genotyping is recommended for the detection of IAR–susceptible individuals among potential breeding stallions. Successful use of sperm as a source of DNA and RNA propagates non-invasive sample procurement for fertility genomics in animals and humans. Impaired acrosomal reaction (IAR) of sperm causes male subfertility in humans and animals, and currently the molecular causes of the condition are not known. Here we report the mapping, identification, and functional analysis of a susceptibility locus for IAR in stallions. The candidate region was mapped to horse chromosome 13 by SNP genotyping and GWAS of 7 IAR affected and 44 control Thoroughbred stallions. Re-sequencing and case-control analysis of functionally relevant candidate genes in the region identified FKBP6 gene as a significantly associated locus. The association was confirmed by genotyping 265 male horses of multiple breeds. FKBP6 belongs to the immunophilins FKBP family known to be involved in meiosis, calcium homeostasis, clathrin-coated vesicles, and membrane fusions. We showed that the equine FKBP6 is exclusively and monoallelically expressed in testis and sperm and has 5 different transcripts, of which 4 were novel. Overall, FKBP6 was considered a susceptibility gene of incomplete penetrance for IAR in stallions and a candidate gene for male subfertility in other mammals. Successful use of sperm as a source of DNA and RNA propagates non-invasive sample procurement for fertility genomics in animals and humans.